New study to test anthrax vaccine after mass exposure
NCT ID NCT07268612
First seen Dec 16, 2025 · Last updated May 20, 2026 · Updated 21 times
Summary
This study looks at 250 people who received the CYFENDUS anthrax vaccine after being exposed to anthrax bacteria. Researchers want to see if the vaccine, given with antibiotics, helps prevent serious anthrax disease. The study will track how many people develop inhalational anthrax or anthrax meningitis after vaccination.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTHRAX are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.